Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 22

Trial Status

Completed4
Terminated1
Other1

Role Distribution

Principal Investigator6
PI Rate100%

Activity Timeline

Clinical Trials (6)

NCT00637247Phase 2Completed
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
Pancreatic Neoplasms
PrincipalinvestigatorStart date: 2008-04-01
Circulating Tumor Cells in Patients With Metastatic Colorectal Cancer
Colorectal CancerNeoplasm Metastasis
Principalinvestigator
NCT00327327Phase 1Completed
Safety Study of Imexon Plus Gemcitabine in Untreated Pancreatic Adenocarcinoma
Pancreatic Adenocarcinoma
Principalinvestigator
NCT00761345Phase 1Completed
Study of Low-Dose Fractionated Radiotherapy in Patients With Locally Advanced Metastatic Pancreatic Cancer
Metastatic Pancreatic CancerPancreatic Carcinoma Non-resectable
Principalinvestigator

Research Network

Collaboration Network

3 collaborators·2 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Mark Zalupski, MD

University of Michigan

Moderately Similar
4 trials

Shared therapeutic areas:

Cancer of PancreasPancreatic AdenocarcinomaPancreatic Neoplasms

Worked with same sponsors:

AmpliMed Corporation
Collaborated on 1 trial
Similarity Score34%

Evan Hersh, MD

AmpliMed Corporation

Related
4 trials

Shared therapeutic areas:

Neoplasm MetastasisPancreatic Neoplasms

Worked with same sponsors:

AmpliMed Corporation
Collaborated on 1 trial
Similarity Score24%

Ajay Goel, PhD

City of Hope Medical Center

Related
24 trials

Shared therapeutic areas:

Colorectal CancerColorectal NeoplasmsPancreatic Adenocarcinoma+2 more
Similarity Score19%

Tim F Greten, M.D.

National Cancer Institute (NCI)

Related
22 trials

Shared therapeutic areas:

Colorectal CancerColorectal NeoplasmsCancer of Pancreas+2 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score19%

E-mail: ClinicalTrials@ ImClone.com

Eli Lilly and Company

Related
22 trials

Shared therapeutic areas:

Colorectal CancerColorectal NeoplasmsNeoplasm Metastasis+1 more
Similarity Score15%

Jeong Min Lee, MD

Seoul National University Hospital

Related
34 trials

Shared therapeutic areas:

Neoplasm MetastasisColorectal CancerCancer of Pancreas
Similarity Score11%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Cancer of PancreasColorectal CancerMetastatic Pancreatic Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score11%

Saleh K Saleh, MD

Minia University

Related
23 trials

Shared therapeutic areas:

Cancer of PancreasPancreatic NeoplasmsColorectal Cancer
Similarity Score11%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

Neoplasm MetastasisCancer of Pancreas
Similarity Score8%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Colorectal CancerColorectal Neoplasms
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (6)

Showing 6 of 6 trials

NCT00637247Phase 2PrincipalInvestigator

A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer

Pancreatic Neoplasms
Completed
NCT00133913PrincipalInvestigator

Circulating Tumor Cells in Patients With Metastatic Colorectal Cancer

Colorectal CancerNeoplasm Metastasis
Unknown
NCT00321100Phase 2PrincipalInvestigator

Combination of Cetuximab, Capecitabine, and Oxaliplatin With or Without Bevacizumab

Colorectal Neoplasms
Terminated
NCT00327327Phase 1PrincipalInvestigator

Safety Study of Imexon Plus Gemcitabine in Untreated Pancreatic Adenocarcinoma

Pancreatic Adenocarcinoma
Completed
NCT00761345Phase 1PrincipalInvestigator

Study of Low-Dose Fractionated Radiotherapy in Patients With Locally Advanced Metastatic Pancreatic Cancer

Metastatic Pancreatic CancerPancreatic Carcinoma Non-resectable
Completed
NCT00900016PrincipalInvestigator

Studying Fibroblast Activity in Patients With Localized Pancreatic Cancer Undergoing Surgery

Pancreatic Cancer
Completed

All 6 trials loaded